Adeshwar Meditex Board of Directors
Get the latest insights into the leadership at Adeshwar Meditex. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Ashalata Baburao Raut | Managing Director |
| Prithvi Singh | Non Executive Director |
| Krishnojirao Nagaraja Rao | Chairman |
| Abhinandan Nagaraja Rao | Whole Time Director |
| Shailesh Vinayak Rajpure | Executive Director |
| Benegal Parameshwara Udpa | Non Executive Independent Director |
| Arun Koli | Non Executive Independent Director |
| Vishal Jain | Company Secretary & Compliance Officer |
| Satish Chudekar | Non Independent & Non Executive Director |
| Raghupathy K Bhat | Non Executive Independent Director |
Adeshwar Meditex FAQs
The board at Adeshwar Meditex consists of experienced professionals, including Ashalata Baburao Raut, Prithvi Singh, and others, overseeing the company’s strategic and corporate governance.
Directors at Adeshwar Meditex are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Ashalata Baburao Raut is the current chairman at Adeshwar Meditex.
Executive directors at Adeshwar Meditex are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Adeshwar Meditex adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Adeshwar Meditex, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
